Description
MBS is pleased to release three new monoclonal antibodies to Cystatin C, available in two matched pair combinations. The pairs have proven sensitive enough to detect Cystatin C present in serum and purified from urine in the ng/mL range.As always, these antibodies were developed and produced at MBS to allow for extensive product support and maximum price flexibility for bulk sales.
